SLC16A3 and hepatocellular carcinoma: Overall, our study identified a metabolic‐related gene, SLC16A3, which correlates with the tumour microenvironment and validated its immunosuppressive function in the tumour microenvironment through in vivo experiments, providing insights into the interplay between SLC16A3 and the immune landscape within HCC.